NCT03485547 Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Status COMPLETED Phase PHASE1
NCT03484520 A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT03478787 Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03441555 A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT03419403 UNITE Study: Understanding New Interventions With GBM ThErapy Status TERMINATED Phase PHASE3
NCT03415035 Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic Leukemia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03413319 Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104 Status COMPLETED Phase PHASE1
NCT03406156 A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy Status COMPLETED Phase PHASE3
NCT03400306 A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer Status WITHDRAWN Phase PHASE1
NCT03398148 A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE2/PHASE3
NCT03398135 A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03391765 An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP) Status TERMINATED Phase PHASE2
NCT03386513 Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03383263 A Study to Assess Persistence, Adherence and Changes in Disease Activity in the Children Population of Juvenile Arthritis Patients Treated With Adalimumab (HUMIRA®) Status COMPLETED Phase N/A
NCT03379428 Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03374917 A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment Status COMPLETED Phase PHASE1
NCT03368859 A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab Status TERMINATED Phase PHASE2
NCT03362879 COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel Status COMPLETED Phase N/A
NCT03360006 A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer Status TERMINATED Phase PHASE1